PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 33 filers reported holding PROTEON THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $21,000 | -58.0% | 11,300 | -54.8% | 0.00% | -100.0% |
| Q3 2017 | $50,000 | +31.6% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $38,000 | +11.8% | 25,000 | +28.9% | 0.00% | 0.0% |
| Q1 2017 | $34,000 | +47.8% | 19,400 | +61.7% | 0.00% | – |
| Q4 2016 | $23,000 | -79.5% | 12,000 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $112,000 | +16.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $96,000 | +3.2% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $93,000 | -50.0% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $186,000 | +11.4% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $167,000 | -37.7% | 12,000 | -20.0% | 0.00% | -25.0% |
| Q2 2015 | $268,000 | +54.0% | 15,000 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $174,000 | +11.5% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $156,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,017,872 | $27,423,000 | 16.02% |
| Monashee Investment Management LLC | 77,102 | $1,072,000 | 7.40% |
| Deer VII & Co. Ltd. | 315,101 | $4,383,000 | 4.15% |
| RA Capital Management | 1,506,872 | $20,961,000 | 3.01% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $13,679,000 | 2.10% |
| Omega Fund Management, LLC | 250,000 | $3,478,000 | 1.96% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,265,343 | $17,601,000 | 0.68% |
| Perceptive Advisors | 550,000 | $7,650,000 | 0.31% |
| TIVERTON ASSET MANAGEMENT LLC | 375,000 | $5,216,000 | 0.12% |
| Baker Brothers Advisors | 274,617 | $3,820,000 | 0.04% |